Terumo (OTCMKTS:TRUMY) Shares Gap Up – Time to Buy?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped up before the market opened on Tuesday. The stock had previously closed at $14.65, but opened at $15.81. Terumo shares last traded at $15.23, with a volume of 1,310 shares traded.

Analysts Set New Price Targets

Several analysts have recently issued reports on TRUMY shares. Zacks Research raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 13th. Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. Two analysts have rated the stock with a Strong Buy rating. Based on data from MarketBeat.com, the stock has a consensus rating of “Strong Buy”.

Terumo Stock Up 3.9%

The firm has a market cap of $22.45 billion, a PE ratio of 21.44 and a beta of 0.77. The company has a quick ratio of 1.37, a current ratio of 2.19 and a debt-to-equity ratio of 0.13. The business has a 50-day moving average price of $15.06 and a two-hundred day moving average price of $14.25.

Terumo (OTCMKTS:TRUMY) last released its earnings results on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. Terumo had a return on equity of 10.44% and a net margin of 13.83%. The firm had revenue of $1.97 billion during the quarter, compared to analyst estimates of $1.84 billion. On average, equities research analysts expect that Terumo Corp. will post 0.86 EPS for the current year.

Terumo Company Profile

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells medical devices and healthcare products. Its offerings support hospitals, physicians and other healthcare providers across areas including cardiovascular care, interventional procedures, blood management, cell and gene therapies, and general medical care.

The company’s products include catheters, guidewires, stents and other devices used in cardiovascular and endovascular procedures, as well as blood bags, apheresis systems, cell-processing technologies, infusion and injection products, and hospital equipment.